0 %

LAMP Human Prothrombin mutation KIT

The LAMP Human Prothrombin mutation KIT is an in vitro diagnostic test intended for the qualitative detection of Factor II G20210A by Loop-mediated isothermal amplification (LAMP) on EDTA whole blood and extracted DNA. This assay is dedicated to professional use in diagnostic laboratories. The device is not for self-testing.

Regulatory Status: CE-IVD

Format: 24 / 96 reactions

Linked disease: Thrombophilia 

Mutation: c.*97G>A (G20210A or 20210G>A)

Method: LAMP + meting curve analysis 

Sample: EDTA whole blood - no DNA extraction required - or extracted DNA

Compatible instruments: LightCycler 480 I&II / Cobas z 480 (Roche); CFX96 / CFX Opus 96 (Bio-Rad); QuantStudio 1/3/5 & 6/7 Flex (Applied Biosystems); MIC qPCR (Bio Molecular Systems); LC-Genie III & Genie HT (Optigene)

Software / result interpretation: Automated genotype calling via GeneFox software; mandatory visual confirmation of the melting curve

Turn around time: < 1h 

General information

Advantages

icon fast
Fast
icon No-DNA-extraction
No DNA extraction
icon comprehensive
Compatible with a variety of qPCR machines
icon easy-to-use
Automatic interpretation of the results

Linked products

LaCar
The LAMP Human FV LEIDEN mutation KIT is an in vitro diagnostic test intended for the qualitative detection of Factor V Leiden G1691A by Loop-mediated isothermal amplification (LAMP) on EDTA whole blood and extracted DNA.
LaCar
The LAMP Human FII&FVL duplex KIT is an in vitro diagnostic test intended for the qualitative detection of the Factor II G20210A and the Factor V Leiden G1691A polymorphisms by Loop-mediated isothermal amplification (LAMP) on EDTA whole blood and extracted DNA.

The LC-FII-LP kit uses loop mediated isothermal amplification, a robust amplification method using four to six primers per target, that can be directly used on lysed EDTA-whole blood samples, without DNA purification and on extracted DNA samples from whole blood samples.


The genotyping is performed by melting curve analysis after amplification, using a specific probe and quencher for each target polymorphism.

Test principle

Factor II (prothrombin) gene mutation is one of the primary genetic causes for inherited thrombophilia, a blood coagulation disorder that increases the risk for venous thromboembolism (VTE).  

Factor II mutation c.*97G>A (G20210A or 20210G>A) is located in the gene promotor region and is associated with elevated plasma levels of prothrombin, resulting in an increased risk of blood clot formation. The Allele Frequency of the mutated allele is around 2% in the Caucasian population.

Background Information

You have a question regarding our products ? You want to know more about our method ?

Find out about our other expertises

Genetic testing CE Kits
Newborn Screening
Genetic testing CE Kits
Pharmacogenetics
Contact